MedTrace Logo

Assessment of Human Herpes Virus Reactivation 6 Post Autologous Stem Cells

NCT02090803 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 189

Last updated 2017-09-14

No results posted yet for this study

Summary

The purpose of this study is to assess the human herpes virus reactivation 6 post autologous stem cells in 196 patients. The aim of our study was to describe the incidence of reactivation of HHV-6 in patients requiring autologous HSCT and determine the pathogenic role in this target population.

Conditions

Sponsors & Collaborators

  • Institut de Cancérologie de la Loire

    lead OTHER

Principal Investigators

  • Marie Balsat, MD · Institut de Cancérologie Lucien Neuwirth

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02090803 on ClinicalTrials.gov